Breaking

Locksley Resources LimitedQualifies for Trading on U.S. OTCQX Market
Successful Completion-Impurity Removal Neutralization Tests
Locksley Qualifies for Trading on U.S. OTCQX Market
Successful A$4.5m Two Tranche Placement
Thatcher at 100: Lessons in civility, strength and enduring alliances
Trump heralds ‘golden age of the Middle East’ in address to Israeli Knesset hours after hostages come home
Instead of impeachment, Dems are using Article II challenges to impede Trump this time
Squad 2.0: Meet America’s next wave of radical Democrats shaping the party’s future

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

June 4, 2025 Investing 1 Min Read

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

GOP senators express ‘concerns,’ ‘skepticism’ over Trump’s spending bill after Musk rant

Top

Type above and press Enter to search. Press Esc to cancel.